[{"address1": "4300 El Camino Real", "address2": "Suite 210", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 351 4495", "website": "https://unicycive.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shalabh K. Gupta M.D., MPA", "age": 51, "title": "Founder, Chairman, CEO & President", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1100000, "exercisedValue": 0, "unexercisedValue": 141224}, {"maxAge": 1, "name": "Dr. Pramod  Gupta Ph.D.", "age": 64, "title": "Executive Vice President of Pharmaceutical & Business Operations", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 40969}, {"maxAge": 1, "name": "Mr. Douglas  Jermasek M.B.A.", "age": 62, "title": "Executive Vice President of Corporate Strategy", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 412500, "exercisedValue": 0, "unexercisedValue": 42029}, {"maxAge": 1, "name": "Mr. John W. Townsend CPA", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 197864, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6099, "open": 0.6161, "dayLow": 0.59, "dayHigh": 0.646, "regularMarketPreviousClose": 0.6099, "regularMarketOpen": 0.6161, "regularMarketDayLow": 0.59, "regularMarketDayHigh": 0.6417, "payoutRatio": 0.0, "beta": 2.232, "forwardPE": -3.0219998, "volume": 1282655, "regularMarketVolume": 1282655, "averageVolume": 1232874, "averageVolume10days": 1022000, "averageDailyVolume10Day": 1022000, "bid": 0.5696, "ask": 0.6392, "bidSize": 1, "askSize": 1, "marketCap": 62734300, "fiftyTwoWeekLow": 0.202, "fiftyTwoWeekHigh": 1.8, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 0.66358, "twoHundredDayAverage": 0.57395, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 31765428, "profitMargins": 0.0, "floatShares": 56092616, "sharesOutstanding": 103796000, "sharesShort": 823318, "sharesShortPriorMonth": 1235170, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.007900001, "heldPercentInsiders": 0.06122, "heldPercentInstitutions": 0.70482004, "shortRatio": 0.72, "shortPercentOfFloat": 0.0085, "impliedSharesOutstanding": 103796000, "bookValue": 0.285, "priceToBook": 2.1207018, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -24097000, "trailingEps": -0.46, "forwardEps": -0.2, "enterpriseToEbitda": -1.09, "52WeekChange": -0.65921783, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 0.6044, "targetHighPrice": 9.0, "targetLowPrice": 2.0, "targetMeanPrice": 5.5, "targetMedianPrice": 5.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 32347000, "totalCashPerShare": 0.312, "ebitda": -29151000, "totalDebt": 807000, "quickRatio": 3.093, "currentRatio": 3.608, "totalRevenue": 0, "debtToEquity": 2.898, "revenuePerShare": 0.0, "returnOnAssets": -0.62847, "returnOnEquity": -1.4705299, "grossProfits": 0, "freeCashflow": -22025376, "operatingCashflow": -26466000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "UNCY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_605176729", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.9081933, "regularMarketPrice": 0.6044, "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1740169056, "firstTradeDateMilliseconds": 1626096600000, "shortName": "Unicycive Therapeutics, Inc.", "longName": "Unicycive Therapeutics, Inc.", "hasPrePostMarketData": true, "regularMarketChange": -0.0055000186, "regularMarketDayRange": "0.59 - 0.6417", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1232874, "fiftyTwoWeekLowChange": 0.40239996, "fiftyTwoWeekLowChangePercent": 1.9920789, "fiftyTwoWeekRange": "0.202 - 1.8", "fiftyTwoWeekHighChange": -1.1956, "fiftyTwoWeekHighChangePercent": -0.66422224, "fiftyTwoWeekChangePercent": -65.92178, "epsTrailingTwelveMonths": -0.46, "epsForward": -0.2, "epsCurrentYear": -0.53, "priceEpsCurrentYear": -1.1403774, "fiftyDayAverageChange": -0.05918002, "fiftyDayAverageChangePercent": -0.08918295, "twoHundredDayAverageChange": 0.030449986, "twoHundredDayAverageChangePercent": 0.05305338, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-13", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Unicycive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]